Cargando…

Lipidation of Class IV CdiA Effector Proteins Promotes Target Cell Recognition during Contact-Dependent Growth Inhibition

Contact-dependent growth inhibition (CDI) systems enable the direct transfer of protein toxins between competing Gram-negative bacteria. CDI(+) strains produce cell surface CdiA effector proteins that bind specific receptors on neighboring bacteria to initiate toxin delivery. Three classes of CdiA e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Halvorsen, Tiffany M., Garza-Sánchez, Fernando, Ruhe, Zachary C., Bartelli, Nicholas L., Chan, Nicole A., Nguyen, Josephine Y., Low, David A., Hayes, Christopher S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510554/ https://www.ncbi.nlm.nih.gov/pubmed/34634941 http://dx.doi.org/10.1128/mBio.02530-21

Ejemplares similares

CdiA Effectors Use Modular Receptor-Binding Domains To Recognize Target Bacteria
por: Ruhe, Zachary C., et al.
Publicado: (2017)

Delivery of CdiA Nuclease Toxins into Target Cells during Contact-Dependent Growth Inhibition
por: Webb, Julia S., et al.
Publicado: (2013)

CdiA Effectors from Uropathogenic Escherichia coli Use Heterotrimeric Osmoporins as Receptors to Recognize Target Bacteria
por: Beck, Christina M., et al.
Publicado: (2016)

CDI Systems Are Stably Maintained by a Cell-Contact Mediated Surveillance Mechanism
por: Ruhe, Zachary C., et al.
Publicado: (2016)

Capsule Protects Acinetobacter baumannii From Inter-Bacterial Competition Mediated by CdiA Toxin
por: Krasauskas, Renatas, et al.
Publicado: (2020)

Erratum: Capsule Protects Acinetobacter baumannii From Inter-Bacterial Competition Mediated by CdiA Toxin
Publicado: (2020)

Genetic Analysis of the CDI Pathway from Burkholderia pseudomallei 1026b
por: Koskiniemi, Sanna, et al.
Publicado: (2015)

Genetic Evidence for SecY Translocon-Mediated Import of Two Contact-Dependent Growth Inhibition (CDI) Toxins
por: Jones, Allison M., et al.
Publicado: (2021)

Receptor Polymorphism Restricts Contact-Dependent Growth Inhibition to Members of the Same Species
por: Ruhe, Zachary C., et al.
Publicado: (2013)

Identification of Functional Toxin/Immunity Genes Linked to Contact-Dependent Growth Inhibition (CDI) and Rearrangement Hotspot (Rhs) Systems
por: Poole, Stephen J., et al.
Publicado: (2011)

Functional Characterization of Pseudomonas Contact Dependent Growth Inhibition (CDI) Systems
por: Mercy, Chryslène, et al.
Publicado: (2016)

Correction: Functional Characterization of Pseudomonas Contact Dependent Growth Inhibition (CDI) Systems
por: Mercy, Chryslène, et al.
Publicado: (2016)

Escherichia coli EC93 deploys two plasmid-encoded class I contact-dependent growth inhibition systems for antagonistic bacterial interactions
por: Wäneskog, Marcus, et al.
Publicado: (2021)

Class II contact‐dependent growth inhibition (CDI) systems allow for broad‐range cross‐species toxin delivery within the Enterobacteriaceae family
por: Virtanen, Petra, et al.
Publicado: (2019)

Structural basis for effector recognition by an antibacterial type IV secretion system
por: Oka, Gabriel U., et al.
Publicado: (2021)

Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI
por: Finn, Elaine, et al.
Publicado: (2021)

Doctor, my patient has CDI and should continue to receive antibiotics. The (unresolved) risk of recurrent CDI
por: Castro, Iván, et al.
Publicado: (2019)

A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018
por: Viprey, Virginie F, et al.
Publicado: (2022)

JBoss Weld CDI for Java platform
por: Finnegan, Ken
Publicado: (2013)

Focusing stewardship to help tackle CDI
Publicado: (2020)

SMT19969 for Clostridium difficile infection (CDI): in vivo efficacy compared with fidaxomicin and vancomycin in the hamster model of CDI
por: Sattar, Abdul, et al.
Publicado: (2015)

684. Characteristics of Patients with Initial Clostridioides difficile Infection (CDI) That Are Associated With Increased Risk of Multiple CDI Recurrences
por: Guh, Alice, et al.
Publicado: (2023)

Use of Electronic Data to Identify Risk Factors Associated with Clostridium difficile Infection (CDI) and to Develop CDI Risk Scores
por: Aukes, Laurie, et al.
Publicado: (2017)

Functional and Structural Diversity of Bacterial Contact-Dependent Growth Inhibition Effectors
por: Cuthbert, Bonnie J., et al.
Publicado: (2022)

Bezlotoxumab (BEZ) for Prevention of Clostridium Difficile Infection (CDI) Recurrence (rCDI): Outcomes in Patients with Substantial Renal Impairment (SRI)
por: Golan, Yoav, et al.
Publicado: (2017)

Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI
por: Louie, Thomas J., et al.
Publicado: (2012)

1211. Response to Fecal Microbiota Transplant (FMT) in Refractory Clostridioides difficile Infection (CDI) is Modest Compared to Recurrent CDI in Hospitalized Patients
por: Shin, Jae Hyun, et al.
Publicado: (2020)

The CDI toxin of Yersinia kristensenii is a novel bacterial member of the RNase A superfamily
por: Batot, Gaëlle, et al.
Publicado: (2017)

New advances in the treatment of Clostridium difficile infection (CDI)
por: Hedge, Dennis D, et al.
Publicado: (2008)

The burden of CDI in the United States: a multifactorial challenge
por: Feuerstadt, Paul, et al.
Publicado: (2023)

Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study
por: Zilberberg, Marya D, et al.
Publicado: (2014)

Bezlotoxumab (BEZ) for Prevention of Clostridium difficile Infection (CDI) Recurrence (rCDI): Distinguishing Relapse from Reinfection with Whole Genome Sequencing (WGS)
por: Dorr, Mary Beth, et al.
Publicado: (2017)

The N-Terminus of GalE Induces tmRNA Activity in Escherichia coli
por: Ruhe, Zachary C., et al.
Publicado: (2010)

CDI/CDS system-encoding genes of Burkholderia thailandensis are located in a mobile genetic element that defines a new class of transposon
por: Ocasio, Angelica B., et al.
Publicado: (2019)

A 14-day repeat dose oral gavage range-finding study of a first-in-class CDI investigational antibiotic, in rats
por: Sibley, Katherine, et al.
Publicado: (2019)

Clostridioides difficile infection (CDI) during the COVID-19 pandemic
por: Spigaglia, Patrizia
Publicado: (2022)

CDiP technology for reverse engineering of sporadic Alzheimer’s disease
por: Kondo, Takayuki, et al.
Publicado: (2022)

Genotypic Correlation between Cases of Clostridium difficile (CDI) with Community-Onset Diagnosis after Recent Hospital Discharge and Their Prior Unit-Based Contacts
por: Aslam, Anoshé, et al.
Publicado: (2017)

Searching algorithm for type IV secretion system effectors 1.0: a tool for predicting type IV effectors and exploring their genomic context
por: Meyer, Damien F., et al.
Publicado: (2013)

Intravenous Tigecycline Facilitates Cure of Severe Clostridium difficile Infection (CDI) After Failure of Standard Therapy: A Case Report and Literature Review of Tigecycline Use in CDI
por: Navalkele, Bhagyashri D., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_86e3d5ep2d8js2u3rrkq6m08of